Search hospitals > Colorado > Aurora
University of Colorado Cancer Center
Claim this profileAurora, Colorado 80045
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Melanoma
675 reported clinical trials
27 medical researchers
Summary
University of Colorado Cancer Center is a medical facility located in Aurora, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. University of Colorado Cancer Center is involved with conducting 675 clinical trials across 424 conditions. There are 27 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Jessica D. McDermott, and Theresa M. Medina.Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Bradley R. CorrUniversity of Colorado Hospital1 year of reported clinical research
Studies Ovarian Cancer
Studies Cancer
20 reported clinical trials
33 drugs studied
Jose M. PachecoUniversity of Colorado Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
17 reported clinical trials
30 drugs studied
Jessica D. McDermottRocky Mountain Regional VA Medical Center5 years of reported clinical research
Studies Cancer
Studies Lung Cancer
19 reported clinical trials
32 drugs studied
Theresa M. MedinaUniversity of Colorado Hospital4 years of reported clinical research
Expert in Melanoma
Studies Cancer
19 reported clinical trials
26 drugs studied
Clinical Trials running at University of Colorado Cancer Center
Breast Cancer
Tumors
Non-Small Cell Lung Cancer
Solid Tumors
Lung Cancer
Cancer
Ovarian Cancer
Melanoma
Colorectal Cancer
Blood Cancers
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Combo Therapy
for Breast Cancer
This trial tests a new drug, OP-1250, combined with either ribociclib or alpelisib in cancer patients. It aims to see if these combinations are safe and can better stop cancer growth.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Colorado Cancer Center?
University of Colorado Cancer Center is a medical facility located in Aurora, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. University of Colorado Cancer Center is involved with conducting 675 clinical trials across 424 conditions. There are 27 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Jessica D. McDermott, and Theresa M. Medina.
Where is University of Colorado Cancer Center located?
The University of Colorado Cancer Center is situated at 1665 Aurora Ct, Aurora, CO 80045. For access, use I-225 N, exit at Colfax Ave, proceed north, and turn right onto Aurora Ct. The center is located on the left side of the street.
Who should I call to ask about financial aid or insurance network?
**University of Colorado Cancer Center Hospital Financial and Insurance Contacts**
- **Financial Assistance**: Contact the Financial Counseling department at 855.843.3547 for help with federal and state health insurance programs, eligibility, and application processes.
- **Insurance Inquiries**: Reach out to the Insurance & Claims Administration department at 303-860-5676 for insurance claims and administration questions.
- **Billing Assistance**: For billing-related questions, call 866.429.6045 for UCHealth facilities, including the University of Colorado Hospital.
- **CU Medicine Group Billing**: For billing inquiries related to the CU Medicine Group, contact 303.493.7700.
- **Technical Support**: For technical difficulties with online bill payments, call toll-free at 855.395.9031.
What insurance does University of Colorado Cancer Center accept?
The University of Colorado Cancer Center accepts a variety of insurance plans, including CU Health Plans (Exclusive, High Deductible/HSA Compatible, Extended, Kaiser, Medicare), Medicare, and Medicaid. Accepted Medicaid plans include CHP+ (Colorado Access), Colorado Access, Denver Health, and the Colorado Indigent Care Program (CICP), aimed at assisting low-income individuals and families. Patients with out-of-network or limited benefit plans may incur higher out-of-pocket expenses; verifying provider participation and coverage details with the insurance plan is advised before scheduling a visit.
What awards or recognition has University of Colorado Cancer Center received?
The University of Colorado Cancer Center, located in Aurora, Colorado, is recognized as a Comprehensive Cancer Center by the National Cancer Institute (NCI). This designation highlights its extensive contributions to cancer research, clinical trials, prevention, and control. In 2022, the center received its best-ever renewal of this comprehensive status from the NCI and was awarded a $20 million gift to enhance research, clinical trials, and treatments for esophageal and gastric cancer.